| APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT02166255) | Wake Forest University Health Sciences | 2014-12-01 |
| Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer (NCT02273752) | Emory University | 2014-11-01 |
| Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer (NCT01943188) | Stanford University | 2014-05-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery (NCT01892930) | Roswell Park Cancer Institute | 2013-07-11 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer (NCT01826877) | Jonsson Comprehensive Cancer Center | 2013-01-14 |
| Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer (NCT01740154) | Case Comprehensive Cancer Center | 2012-09-01 |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer (NCT01599832) | University of Chicago | 2012-06-01 |
| Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer (NCT01547676) | University of Southern California | 2011-12-01 |
| Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors (NCT01281488) | City of Hope Medical Center | 2011-10-20 |
| Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer (NCT01157091) | City of Hope Medical Center | 2010-12-08 |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies (NCT01243359) | National Cancer Institute (NCI) | 2010-10-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors (NCT01198184) | National Cancer Institute (NCI) | 2010-08-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate (NCT01582009) | Roswell Park Cancer Institute | 2010-03-01 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00684996) | National Cancer Institute (NCI) | 2008-06-01 |
| Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer (NCT00408902) | National Cancer Institute (NCI) | 2006-11-01 |
| AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00348699) | National Cancer Institute (NCI) | 2006-07-01 |
| Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00354250) | National Cancer Institute (NCI) | 2006-05-01 |
| AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer (NCT00303862) | National Cancer Institute (NCI) | 2006-03-01 |
| Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer (NCT00324740) | National Cancer Institute (NCI) | 2006-03-01 |
| Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00324870) | National Cancer Institute (NCI) | 2006-02-01 |
| Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer (NCT00182702) | National Cancer Institute (NCI) | 2005-07-01 |
| Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery (NCT00217542) | National Cancer Institute (NCI) | 2005-07-01 |
| CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00112840) | National Cancer Institute (NCI) | 2005-05-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
| Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT00098618) | National Cancer Institute (NCI) | 2004-10-01 |
| Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00101114) | National Cancer Institute (NCI) | 2004-09-01 |
| Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858) | Fred Hutchinson Cancer Center | 2003-09-01 |
| Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer (NCT00059813) | National Cancer Institute (NCI) | 2003-08-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer (NCT00060307) | National Cancer Institute (NCI) | 2003-05-01 |
| Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer (NCT00032188) | National Cancer Institute (NCI) | 2002-01-01 |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer (NCT00005851) | Fred Hutchinson Cancer Center | 2000-02-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer (NCT00019539) | National Cancer Institute (NCI) | 1998-11-01 |
| flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer (NCT00019396) | National Cancer Institute (NCI) | 1998-02-01 |
| BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer (NCT00040989) | Jonsson Comprehensive Cancer Center | |